A federal ruling could undermine the framework of FDA drug approvals; Florida’s warning on COVID-19 vaccines omits key data; uninsured patients with cancer struggle to find care.
Texas Abortion Ruling Threatens FDA Drug Approval Control
A Texas federal judge’s ruling to repeal the approval of the abortion pill mifepristone by the FDA has the potential to undermine US government authority over the regulation of drug approvals, according to The New York Times. This is the first time a court has pushed toward the removal of an FDA approved drug. If upheld, this decision could result in more lawsuits over FDA approval of other medications and new drugs, legal experts warned.
Florida Cuts Key COVID-19 Vaccine Data from Study
In drafts obtained by the Tampa Bay Times, Florida’s general surgeon warning that the COVID-19 vaccine could increase the risk of cardiac-related death among young men omitted key information that showed the risk was much higher for those who caught the virus, according to The Associated Press. An analysis of these drafts found that records show catching COVID-19 could increase the chance of cardiac-related death, much more than the mRNA shot, was missing from the final version provided by the Florida Department of Health last October. As a result of these findings and other requests by lawmakers and health experts, the Florida Supreme Court has agreed to convene on this issue.
Uninsured Patients Struggle to Find Care Due to the Type of Cancer They Have
A study finds the odds of patients with cancer getting insurance to help cover the cost of treatment is much like a game of roulette, in which it depends on what type of cancer it is, reports Kaiser Health News. The research shows a patient with breast or cervical cancer is more likely to qualify for insurance than a patient with skin cancer, due to a law that extends coverage to lower-income patients with those 2 types of cancers. For patients with other types of cancer, seeking coverage may require a more complicated route, such as qualifying for disability through Social Security Administration first and then applying through Medicaid, which would then include its own long list of eligibility criteria.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More